Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

vasopressin

&times

Overview

What is VASOPRESSIN?

Vasopressin Injection, USP is a sterile solution of synthetic vasopressin of the posterior pituitary gland for intramuscular (IM) or subcutaneous use. It is substantially free from the oxytocic principle and is standardized to contain 20 pressor units/mL. The chemical name is Vasopressin, 8-L-arginine and has the following structural formula:

Each mL contains:  20 USP Vasopressin Units, chlorobutanol (anhydrous) 5 mg as preservative; Water for Injection q.s. Glacial acetic acid and/or sodium hydroxide may have been added for pH adjustment (2.4-4.5).



What does VASOPRESSIN look like?



What are the available doses of VASOPRESSIN?

Sorry No records found.

What should I talk to my health care provider before I take VASOPRESSIN?

Sorry No records found

How should I use VASOPRESSIN?

Vasopressin Injection, USP is indicated for prevention and treatment of postoperative abdominal distention, in abdominal roentgenography to dispel interfering gas shadows and in diabetes insipidus.

Vasopressin Injection may be administered IM or subcutaneously.

Ten units (0.5 mL) of Vasopressin Injection will usually elicit full physiologic response in adult patients; 5 units (0.25 mL) will be adequate in many cases. Vasopressin Injection should be given IM at three or four hour intervals as needed. The dosage should be proportionately reduced for pediatric patients. (For an additional discussion of dosage, consult the sections below.)

When determining the dose of Vasopressin Injection for a given case, the following should be kept in mind:

It is particularly desirable to give a dose not much larger than is just sufficient to elicit the desired physiologic response. Excessive doses may cause undesirable side effects-blanching of the skin, abdominal cramps, nausea-which, though not serious, may be alarming to the patient. Spontaneous recovery from such side effects occurs in a few minutes. It has been found that one or two glasses of water given at the time Vasopressin Injection is administered reduces such symptoms.


What interacts with VASOPRESSIN?

Sorry No Records found


What are the warnings of VASOPRESSIN?

Sorry No Records found


What are the precautions of VASOPRESSIN?

Array


What are the side effects of VASOPRESSIN?

Sorry No records found


What should I look out for while using VASOPRESSIN?

Anaphylaxis or hypersensitivity to the drug or its components.

This drug should not be used in patients with vascular disease, especially disease of the coronary arteries, except with extreme caution. In such patients, even small doses may precipitate anginal pain, and with larger doses, the possibility of myocardial infarction should be considered. 

Vasopressin may produce water intoxication. The early signs of drowsiness, listlessness and headaches should be recognized to prevent terminal coma and convulsions.


What might happen if I take too much VASOPRESSIN?

Sorry No Records found


How should I store and handle VASOPRESSIN?

Storage: Store Naftifine Hydrochloride Cream USP, 2% at ° [see USP Controlled Room Temperature].Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Do not freeze.Vial stoppers do not contain natural rubber latex.APPAPP PHARMACEUTICALS, LLCSchaumburg, IL 6017345875ERevised:  March 2010


&times

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

The antidiuretic action of vasopressin is ascribed to increasing reabsorption of water by the renal tubules.

Vasopressin can cause contraction of smooth muscle of the gastrointestinal tract and of all parts of the vascular bed, especially the capillaries, small arterioles and venules with less effect on the smooth musculature of the large veins. The direct effect on the contractile elements is neither antagonized by adrenergic blocking agents nor prevented by vascular denervation. 

Following subcutaneous or intramuscular administration of vasopressin injection, the duration of antidiuretic activity is variable but effects are usually maintained for 2 to 8 hours. 

The majority of a dose of vasopressin is metabolized and rapidly destroyed in the liver and kidneys. Vasopressin has a plasma half-life of about 10 to 20 minutes. Approximately 5% of a subcutaneous dose of vasopressin is excreted in urine unchanged after 4 hours.

Non-Clinical Toxicology
Anaphylaxis or hypersensitivity to the drug or its components.

This drug should not be used in patients with vascular disease, especially disease of the coronary arteries, except with extreme caution. In such patients, even small doses may precipitate anginal pain, and with larger doses, the possibility of myocardial infarction should be considered. 

Vasopressin may produce water intoxication. The early signs of drowsiness, listlessness and headaches should be recognized to prevent terminal coma and convulsions.

Vasopressin should be used cautiously in the presence of epilepsy, migraine, asthma, heart failure or any state in which a rapid addition to extracellular water may produce hazard for an already overburdened system.

Chronic nephritis with nitrogen retention contraindicates the use of vasopressin until reasonable nitrogen blood levels have been attained.

Local or systemic allergic reactions may occur in hypersensitive individuals. The following side effects have been reported following the administration of vasopressin:

Body as a Whole

Anaphylaxis (cardiac arrest and/or shock) has been observed shortly after injection of vasopressin.

Cardiovascular

Cardiac arrest, circumoral pallor, arrhythmias, decreased cardiac output, angina, myocardial ischemia, peripheral vasoconstriction, and gangrene.

Gastrointestinal

Abdominal cramps, nausea, vomiting, passage of gas.

Nervous System

Tremor, vertigo, "pounding" in head.

Respiratory

Bronchial constriction.

Skin and Appendages

Sweating, urticaria, cutaneous gangrene.

Overdosage

Water intoxication may be treated with water restriction and temporary withdrawal of vasopressin until polyuria occurs. Severe water intoxication may require osmotic diuresis with mannitol, hypertonic dextrose, or urea alone or with furosemide.

&times

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

&times

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
&times

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
&times

Tips

Tips

&times

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).